Anpassung von Suchheuristiken für ereignisdiskrete Modelle

8 I4 = I1I2, I5 = I1I3 6 26−1 VI 32 I6 = I1I2I3I4I5 26−2 IV 16 I5 = I1I2I3, I6 = I2I3I4 26−3 III 8 I4 = I1I2, I5 = I1I3, I6 = I2I3 7 27−1 VII 64 I7 = I1I2I3I4I5I6 27−2 IV 32 I6 = I1I2I3I4, I7 = I1I2I4I5 [...] 28−4 IV 16 I5 = I1I2I3, I6 = I1I2I4, I7 = I1I3I4, I8 = I2I3I4 9 29−2 VI 128 I8 = I1I3I4I6I7, I9 = I2I3I5I6I7 29−3 IV 64 I7 = I1I2I3I4, I8 = I1I3I5I6, I9 = I3I4I5I6 29−4 IV 32 I6 = I1I2I3I5, I7 = I1I2I4I5 [...] 16 I5 = I1I2I3, I6 = I1I3I4, I7 = I2I3I4 27−4 III 8 I4 = I1I2, I5 = I1I3, I6 = I2I3, I7 = I1I2I3 8 28−1 VIII 128 I8 = I1I2I3I4I5I6I7 28−2 V 64 I7 = I1I2I3I4, I8 = I1I2I5I6 28−3 IV 32 I6 = I1I2I3, I7 = I1I2I4 …

Microsoft Word - PflaumerRiskAnalysis

different assumptions r=0.1 r=0.4 r=0.7 r=1 m 0C Index 0C Index 0C Index 0C Index 0 6,502 1.00 6,502 1.00 6,502 1.00 6,502 1.00 1 7,043 1.08 8,461 1.30 9,673 1.49 10,750 1.65 2 7,088 1.09 9,037 1.39 11 [...] standard deviation, which is calculated to be 0 6,502C  . The relative uncertainty interval is therefore 1 10 2 10 1 1 1.12 1.12 1 19,573 3 1 1 0.12 1.12 1 6,502 n n q q U q q             . In [...] 34 4 7,092 1.09 9,286 1.43 12,387 1.90 16,627 2.56 5 7,092 1.09 9,305 1.43 12,631 1.94 17,685 2.72 6 7,092 1.09 9,312 1.43 12,763 1.96 18,473 2.84 7 7,092 1.09 9,314 1.43 12,830 1.97 19,035 2.93 8 7,092 …

2 2 2 2 0 0 0 hIL1B interleukin 1 beta, human 2 ng/mL 10 ng/mL 50 ng/mL 2 2 2 2 2 2 2 2 2 hIL6 interleukin 6, human 2 ng/mL 10 ng/mL 50 ng/mL 2 2 2 2 2 2 2 2 2 HPL haloperidol 1 µM 4 µM 20 µM 2 2 2 2 2 [...] SLP sulpiride NA NA 1000 µM 5000 µM 0 0 0 0 2 2 0 2 2 SS sulfasalazine 6 µM 30 µM 150 µM 2 2 2 2 2 2 2 2 2 SST simvastatin NA NA 6 µM 30 µM 0 0 0 0 2 2 0 2 2 SUL sulindac NA NA 600 µM 3000 µM 0 0 0 0 2 [...] µM 0 0 0 0 0 0 0 2 2 ADP adapin 3 µM 15 µM 75 µM 2 2 2 2 2 2 2 2 2 AFB1 aflatoxin B1 0 µg/mL 1 µg/mL 6 µg/mL 0 0 0 2 2 2 2 2 2 AJM ajmaline NA NA 60 µM 300 µM 0 0 0 0 2 2 0 2 2 AM amiodarone 0 µM 1 µM 7 …

3 4 5 6 7 8 b−→ a−→ 2 1 a−→ 2 2 a−→ 2 3 b−→ 2 3 a−→ 2 6 3 1 a−→ 2 6 3 2 b−→ 2 5 9 10 11 12 13 14 15 a−→ 2 9 5 1 b−→ 2 6 b−→ 2 6 a−→ 2 12 6 1 a−→ 2 12 6 2 a−→ 2 12 6 3 a−→ 2 12 6 4 16 17 b−→ 2 12 6 4 a−→ [...] from the border at position 2 to the border at position 6, namely (3+2)/[(6−2)+(8−6+1)] = 5/7 > 2/(8− 6 + 1) = 2/3, we can conclude that position 6 is no longer a border. This is reflected in summary S8 [...] accurate. 2 4 6 8 10 12 14 16 18 20 22 0 100 5 103 1 104 2 104 2 104 2 104 3 104 4 104 4 104 5 104 # bo rd er s stream size maximum average Figure 6. Size of the summaries for a real-life dataset 6. Experiments …

p : / / s fb 87 6 . de / t e l e s c o p e D a t a _ ${ copy . i d } . f i t s " / > < p r o c e s s i n p u t =" f a c t : ${ copy . i d } " c o p i e s =4> . . . < / p r o c e s s > 6 P o S ( I C R C [...] P o S ( I C R C 2 0 1 5 ) 8 6 5 FACT-Tools – Streamed Real-Time Data Analysis K. A. Brügge b∗, M. L. Ahnena, M. Balboc, M. Bergmannd , A. Bilanda, C. Bockermanne, T. Bretza, J. Bussb, D. Dornerd , S. Eineckeb [...] the data from the FACT Cherenkov telescope. The 34th International Cosmic Ray Conference, 30 July – 6 August, 2015 The Hague, The Netherlands c© Copyright owned by the author(s) under the terms of the Creative …

Isolation, Charakterisierung und hepatische Differenzierung von mesenchymalen Stammzellen aus adipös

iche Zellen zeigten eine hohere enzymatische Aktivitat von Phase I Enzymen (CYP1A1/2, CYP2A6, CYP2D6, CYP2B6, CYP3A4) und Phase II Enzymen im Vergleich zu undifferenzierten Zellen. Eine starke Expression [...] fibroblast-like Ad-MSCs. Generated differentiated cells had higher phase I (CYP1A1/2, CYP2E1, CYP2B6, CYP3A4) and phase II activities compared to the undifferentiated cells. A strong expression of CYP3A7 [...] im Vergleich zu den kryokonservierten hHeps keine Einbusen dieser metabolischen Fahigkeit nach einer 6 monatigen Kryokonservierung auf. Aufgrund dieser Ergebnisse konnten die mit dem in dieser Arbeit en …